QUOTE AND NEWS
Biomass Magazine  Apr 11  Comment 
Ceres Inc. released its second quarter financial results and an update on its efforts in Brazil during a webcast on April 10. The company said it has increased its planting of sorghum in Brazil, where it is pursuing ethanol and biomass power markets.
Agrimoney.com  Apr 11  Comment 
The seeds group says it has lost more than one-quarter of its sorghum evaluation plots to the Brazilian drought which has sent coffee prices soaring
SeekingAlpha  Apr 11  Comment 
Ceres, Inc. (CERE) F2Q 2014 Earnings Conference Call April 10, 2014 16:30 ET Executives Gary Koppenjan - Director of Investor Relations and Communications Richard Hamilton - President, CEO Paul Kuc - CFO Analysts Caleb...
StreetInsider.com  Apr 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Ceres+%28CERE%29+Tops+Q2+EPS+by+1c/9371870.html for the full story.
DailyFinance  Apr 8  Comment 
SANTA CRUZ, CA -- (Marketwired) -- 04/08/14 -- Zero Motorcycles, the global leader in the electric motorcycle industry, announced today that the Ceres Police Department has purchased three Zero DS Police Motorcycles to be added to...
Benzinga  Apr 4  Comment 
Care.com (NYSE: CRCM) shares touched a new 52-week low of $14.105. Care.com's trailing-twelve-month ROE is -29.34%. Rally Software Development (NYSE: RALY) shares reached a new 52-week low of $12.81. Rally Software's PEG ratio is...
Wall Street Journal  Mar 6  Comment 
Ceres Global gets approval from U.S. and Canadian agencies to link its Saskatchewan terminal to a rail line operated by Burlington Northern Santa Fe.
TheStreet.com  Mar 5  Comment 
NEW YORK (TheStreet) -- Ceres was falling 19.5% to $1.03 Wednesday after the company announced pricing for its 20 million share follow-on offering. The agricultural company priced the public offering of 20 million shares at $1.00 a share. Ceres...
Benzinga  Mar 5  Comment 
MCG Capital (NASDAQ: MCGC) shares reached a new 52-week low of $3.97 after the company reported Q4 results. Ceres (NASDAQ: CERE) shares touched a new 52-week low of $1.01 after the company priced an underwritten public offering of 20,000,000...
DailyFinance  Mar 4  Comment 
SAN FRANCISCO, CA--(Marketwired - March 04, 2014) - What:Teleconference to release new report, " Operation: Hydration - How Providing Water in California Schools Can Help Children Become Healthier Adults" Who:Brigadier GeneralDavid Brahms,...




 

Ceres (NASDAQ:CERE) is a biotechnology company which focuses on agriculture. Ceres sells seeds used to grow plants dedicated for use as biofuel. The seeds Ceres makes are bred to have low inputs, are weather hardy, and can grow at large scales. These dedicated plants compete with corn and sugarcane which are often used as fuelstock.[1]


Business Overview

For the full year ended in August 2011, Ceres reported a total revenue of $6.6M. During the period, the company reported a net loss of $36.3M. This compares with $6.6M in revenue in 2010 and a net loss of $22.6M. The majority of the revenue was from collaborative research and government grants while the largest cost was from research and development. [2]

New Updates

The company's initial public offering of stock on the NASDAQ occurred on February 21, 2012. The company offered 5M shares each for $13. This was below the $16-$17 revised price range. The company was originally planning to price between $21-$23. The deal raised a total of $65M. The lead mangers of the deal were Goldman Sachs Group (GS) and Barclays.[3]

Trends & Forces

Dependence on Government Grants

Historically, much of Ceres' revenue has been from government grants. This is part of the US government's goal to encourage the growth in biofuels. If these subsidies are removed, then Ceres will be impacted. This could happen if alternate forms of energy are discovered or if demand for a decrease in overall government spending rises. [4]


  1. CERE S-1/A 2012 PROSPECTUS SUMMARY "Our Company" pg 1
  2. CERE S-1/A 2012 PROSPECTUS SUMMARY "SUMMARY CONSOLIDATED FINANCIAL DATA" pg 10
  3. Renaissance Capital - IPO Home "Ceres prices IPO at $13, below revised range; insiders expected to have purchased 20% of the deal" 22 Feb 2012
  4. CERE S-1/A 2012 PROSPECTUS SUMMARY "RISK FACTORS" pg 13-21
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki